Sarah C J Jorgensen - Concepedia

Author

Sarah C J Jorgensen

Also Known As

S. C. J. Jorgensen, S. Jorgensen, S.C.J. Jorgensen, Sarah C J Jorgensen, Sarah C. J. Jorgensen, Sarah C.J. JORGENSEN, Sarah C.J. Jorgensen, Sarah CJ Jorgensen, Sarah Jorgensen, Sarah C J Jorgensen

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences University of Toronto Henry Ford Hospital Detroit Medical Center

About

Sarah C J Jorgensen is an author at Wayne State University specializing in medicine, public health, and risk factors.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	74
2	Public Health	2	2	63
3	Nursing	1	1	17
4	Emergency Medicine	1	1	46
5	Obstetrics	1	1	17

Sarah C J Jorgensen

Publications

936

Citations

H-Index

Page 1

	Year	Citations
Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections Sarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, Open Forum Infectious Diseases	2019	130
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study Sarah C J Jorgensen, Evan J Zasowski, Trang D Trinh, Clinical Infectious Diseases	2019	92
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists Lisa Hong, Kevin J. Downes, Alireza FakhriRavari, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2023	84
Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections Sarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, Antimicrobial Agents and Chemotherapy	2020	53
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections Sara Alosaimy, Sarah C J Jorgensen, Abdalhamid M Lagnf, Open Forum Infectious Diseases	2020	52
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i> Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, Open Forum Infectious Diseases	2021	51
Risk factors for early return visits to the emergency department in patients with urinary tract infection Sarah C J Jorgensen, Mira Zurayk, Samantha L Yeung, The American Journal of Emergency Medicine Emergency CareEmergency DepartmentPatient SafetyHealthcare-associated InfectionEmergency Department Administration	2017	46
Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study Sarah C J Jorgensen, Alejandro Hernandez, Deshayne B. Fell, BMJ	2023	46
Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy Sarah C J Jorgensen, Samantha S. M. Drover, Deshayne B. Fell, JAMA Pediatrics	2023	46
Sequential intravenous-to-oral outpatient antibiotic therapy for MRSA bacteraemia: one step closer Sarah C J Jorgensen, Abdalhamid M Lagnf, Sahil Bhatia, Journal of Antimicrobial Chemotherapy	2018	45

Page 1